This is your moment.
Our Sites
We have a number of sites in the UK and Europe. Click on each below to find out about the history of each site and what we do.
CRL Leiden is conveniently located nearby the center of Leiden, in the largest life science cluster of the Netherlands: Leiden Bio Science Park. From the Leiden facility we offer clients access to (high throughput) phenotypic screening in human (primary) cell based assays. We are well equipped to perform the development and/or optimization of basic and more complex cell biological or biochemical assays.
CRL Beerse was founded in October 2017 and is located on the campus of Janssen Pharmaceutica in Beerse, Belgium. As part of Johnson & Johnson, Janssen Pharmaceutica focuses its research on six pathological areas: oncology, neurosciences, infectious diseases and vaccines, immunology, cardiovascular and metabolic disorders and pulmonary hypertension.
The High Peak, UK facility is a specialist biotechnology site with proprietary Cell Microarray Technology located in the heart of the UK’s Peak District national park. This site provides unique receptor ID/off-target screening services to accelerate, inform, and improve the safety of the discovery and pre-clinical development process for clients. We are recognized as leading technology within the biotherapeutic field.
.png)
The CRL Harlow site is located at Spire Green approximately 20 miles North East of London. It is perfectly located to service the Golden Triangle of research (Oxford, Cambridge, London).
We currently have 105 staff on site with over 90 highly qualified scientists in the broad areas of chemistry and biology.
The CRL saffron Walden site is located on a science park just south of Cambridge UK. It is perfectly located to service the Golden Triangle of research (Oxford, Cambridge, London). The park’s environment and facilities have attracted leading bioscience names including AstraZeneca, Lonza and Isogenica, cementing its reputation as a prime location at the centre of innovation within the South Cambridgeshire Biotech Cluster.
Charles River's Discovery site in Portishead provides drug discovery services to a range of partners across the therapeutic
areas of immunology, immuno-oncology, inflammation and bacterial/viral infection. Support spans preclinical development
from early complex cell biology through efficacy models to clinical sample analysis.